ESC 365 - Safe electrophysiologic profile of the neprilysin-inhibitor sacubitril in combination with different antiarrhythmic drugs

ESC Professional Premium Access

Safe electrophysiologic profile of the neprilysin-inhibitor sacubitril in combination with different antiarrhythmic drugs

Session: Pharmacological and metabolic impact on ventricular arrhythmias

Topic: Drug Treatment of Ventricular Arrhythmias

Speaker: Professor G. Frommeyer (Munster, DE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Gerrit Frommeyer

University Hospital of Munster, Munster (Germany)

0 follower

3 more presentations in this session

Amiodarone and ventricular fibrillation amplitude of spectral area in patients with out-of-hospital cardiac arrest. Is there an effect?

Speaker: Doctor F. Gentile (Pavia, IT)

Clinical features of drug-induced long QT syndrome in a large prospective cohort

Speaker: Doctor J. Guerra (Barcelona, ES)

Bariatric surgery reverses ventricular repolarisation heterogeneity in obesity: mechanistic insights into fat-related arrhythmic risk

Speaker: Ms N. Herath (GB)

Access the full session

Pharmacological and metabolic impact on ventricular arrhythmias

Speakers: Professor G. Frommeyer, Doctor F. Gentile, Doctor J. Guerra, Ms N. Herath

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources